Mariam Khayretdinova
CEO and co-founder

Brainify.AI provides a cloud‑based platform that pairs a portable, medical‑grade EEG headset with AI‑driven analytics to deliver objective, scalable biomarkers of brain health. The system automatically processes and normalizes EEG recordings, generating real‑time risk scores and reports for conditions such as epilepsy, sleep disorders, and cognitive decline, and integrates with EHRs and research workflows.
Raised to date
$150KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Current assessment of brain health relies on expensive, clinic-bound EEG equipment and manual interpretation, limiting large‑scale monitoring and early detection of neurological conditions. The scarcity of standardized, data‑driven tools hampers precision medicine approaches for brain disorders.
Brainify.AI delivers a cloud‑based platform that combines medical‑grade EEG hardware with AI-driven analytics to provide objective, scalable insights into brain health. Users record EEG data with a portable device, which is securely uploaded to the platform where large‑scale signal processing and predictive modeling generate clinically relevant biomarkers. The system produces automated reports that support diagnosis, treatment planning, and longitudinal tracking, enabling clinicians and researchers to apply precision‑medicine strategies without extensive manual analysis.
Primary customers are neurologists, sleep clinics, and research institutions that require reliable EEG analytics for diagnosis, monitoring, and clinical studies.